Continuing trends in pathological stage migration in radical prostatectomy specimens
- PMID: 15283887
- DOI: 10.1016/j.urolonc.2003.11.011
Continuing trends in pathological stage migration in radical prostatectomy specimens
Abstract
Prostate-specific antigen (PSA) screening has resulted in a profound clinical stage migration. Extracapsular extension (ECE) presents a poor prognosis after radical prostatectomy (RP). In this study the trends in rate of ECE for cancers detected by PSA screening between 1987, when PSA screening became routine in the United States, and 2001, were examined. The clinical outcome of patients (total 1505; 888 clinical Tlc, 614 clinical T2, and 3 clinical T3) with prostate cancer diagnosed by PSA screening and treated with RP without neoadjuvant hormonal therapy was analyzed. The primary outcome variable was ECE rate with respect to year of treatment for a given tumor stage, preoperative PSA level, biopsy Gleason score, and surgical Gleason score. Logistic regression analysis was used to identify predictors of ECE. Biochemical relapse-free survival (bRFS) by year of treatment was analyzed by Kaplan-Meier Curve. Rate of ECE decreased from 65.8 to 25.2% during the 15-year study duration. Multivariate analysis of clinical tumor stage, age, preoperative serum PSA level, and Gleason score confirmed that year of treatment was an independent predictor of ECE. Six-year bRFS rates (by years of treatment) were 75.1% for 1987 to 1994 and 82.6% for 1995 to 2001 (P-value = 0.0022). PSA screening has resulted in a downward pathological stage migration. These observations demonstrate improved biochemical failure rates in more recently treated patients.
Copyright 2004 Elsevier Inc.
Similar articles
-
Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.Cancer. 2002 Dec 1;95(11):2302-7. doi: 10.1002/cncr.10977. Cancer. 2002. PMID: 12436435
-
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24. doi: 10.1016/j.ijrobp.2004.06.018. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708249
-
The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy.BJU Int. 2008 Feb;101(3):305-7. doi: 10.1111/j.1464-410X.2007.07273.x. Epub 2007 Oct 17. BJU Int. 2008. PMID: 17941921
-
Prostate biopsy: who, how and when. An update.Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.
-
[Surgical therapy of prostatic carcinoma].Praxis (Bern 1994). 2001 Sep 6;90(36):1516-22. Praxis (Bern 1994). 2001. PMID: 11593907 Review. German.
Cited by
-
Clinical significance of free-to-total prostate-specific antigen (PSA) ratio in advanced prostate cancer patients with PSA less than 0.1 ng/ml after hormone treatment.Korean J Urol. 2012 Mar;53(3):149-53. doi: 10.4111/kju.2012.53.3.149. Epub 2012 Mar 19. Korean J Urol. 2012. PMID: 22468208 Free PMC article.
-
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.Diagn Interv Radiol. 2014 Jul-Aug;20(4):293-8. doi: 10.5152/dir.2014.13319. Diagn Interv Radiol. 2014. PMID: 24808435 Free PMC article.
-
Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?World J Mens Health. 2021 Oct;39(4):705-723. doi: 10.5534/wjmh.190158. Epub 2020 Jun 25. World J Mens Health. 2021. PMID: 32648377 Free PMC article.
-
Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer.World J Urol. 2007 Aug;25(4):367-73. doi: 10.1007/s00345-007-0189-0. Epub 2007 Jun 27. World J Urol. 2007. PMID: 17594100 Review.
-
Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):125-30. doi: 10.1016/j.ijrobp.2009.04.074. Epub 2009 Aug 19. Int J Radiat Oncol Biol Phys. 2010. PMID: 19695789 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous